© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Trinity Biotech plc (TRIB) shows an Average True Range (ATR) of 0.1 and an Enterprise Value of 65.15M. Its average trading volume over the past 3 months is 101.76K, indicating liquidity. These fundamental metrics provide insight into TRIB's underlying financial health and market activity.
Trinity Biotech plc (TRIB) technical indicators as of December 23, 2025: the SMA 20 is -10.42%, SMA 50 at -8.09%, and SMA 200 at 0.99%. The RSI 14 value is 41.68, suggesting its current momentum. These technical analysis signals help assess TRIB's price trends and potential future movements.
Trinity Biotech plc (TRIB) stock performance overview as of December 23, 2025: The 52-week high is $17.2 (currently -74.07% below), and the 52-week low is $0.798 (currently 85.83% above). Over the past year, TRIB's performance is -80.12%, compared to the S&P 500's 10.56% change.
According to market data, Trinity Biotech plc (TRIB) stock's recent performance metrics show that over the last month, TRIB is 5.9%, with a Year-to-Date (YTD) performance of -79.73%. Over the past year, the stock has seen a -80.12% change. These figures summarize TRIB's price movements across various periods, reflecting its historical returns.
According to current financial data, TRIB stock's P/E (TTM) ratio is -0.44, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TRIB, including P/S (0.17), P/B (-0.38), and P/FCF (-0.72), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.